Presentation | Scalability of a Single-use Bioreactor Platform for Biopharmaceutical Manufacturing
Presentation | Scalability of a Single-use Bioreactor Platform for Biopharmaceutical Manufacturing
A presentation by Abhinav A. Shukla, Ph.D., KBI Biopharma's Vice President of Process Development & Manufacturing delivered at the ACC/QbD Conference (Society for Biological Engineering, AIChE), Coronado Island, CA, 2013.
Presentation | Scalability of a Single-use Bioreactor Platform for Biopharmaceutical Manufacturing
Biopharma innovators must rethink CDMO strategies amid new tariffs and the BIOSECURE Act, focusing on long-term defensibility and supplier risk.
KBI's Mammalian Cell Line Development team in Geneva recently published the results of their research in Biotechnology and Bioprocess Engineering.